Preservation and generation of beta cells in type 1 diabetes with novel mimetic peptides [ 1/1/2021 - 12/31/2024 ]

Research Grant

Brief description Type 1 diabetes (T1D) is an autoimmune disease that destroys insulin producing beta cells in the pancreas. It can cause heart and kidney disease, and nerve damage. T1D is treated with insulin injections that can cause life-threatening low blood sugar levels. We have developed a new treatment that may stop beta cell loss, generate new beta cells and remove the need for insulin injections in T1D patients. A positive outcome will identify a completely new T1D treatment option.

Funding Amount $1,096,055

Funding Scheme Ideas Grants

Chief Investigator Prof Kerry-Anne Rye

Notes Ideas Grants